Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v3-FR
Language French French
Date Updated 2018-12-05 2018-12-05
Drug Identification Number 02441535 02441535
Brand name XARELTO XARELTO
Common or Proper name rivaroxaban rivaroxaban
Company Name BAYER INC BAYER INC
Ingredients RIVAROXABAN RIVAROXABAN RIVAROXABAN RIVAROXABAN
Strength(s) 15MG 20MG 15MG 20MG
Dosage form(s) TABLET KIT TABLET KIT
Route of administration ORAL ORAL
Packaging size 49 49
ATC code B01AF B01AF
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-12-01 2018-12-01
Actual discontinuation date 2018-12-01 2018-12-01
Remaining supply date 2018-12-01 2018-12-01
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments